News
Your search is "" and there are 2637 results
【TAA】KLK2
Product Center > Cell lines > TAA
【Proteins】Antibody-related
Product Center > Proteins
【Antibody-related】IGHE(FcεRIα)
Product Center > Proteins > Antibody-related
【TAA】CDCP1
Product Center > Proteins > TAA
【Product Center】HIV-1 Pseudovirus
Product Center > Pseudovirus
【Others】ASGR1
Product Center > Cell lines > Others
【Cytokines】FGFR2
Product Center > Proteins > Cytokines
【Cytokines】IL-31
Product Center > Proteins > Cytokines
【Cytokines】IL-33
Product Center > Proteins > Cytokines
【Immune checkpoints】CD7
Product Center > Cell lines > Immune checkpoints
【Cytokines】FGFR2
Product Center > Cell lines > Cytokines
【Insights】CD38: Sarclisa approved in the US as the first anti-CD38 therapy in combination with standard-of-care treatment for adult patients with newly diagnosed multiple myeloma not eligible for transplant
2024-09-23
【Insights】CD40: UCB and Biogen Announce Positive Topline Results From Phase 3 Study of Dapirolizumab Pegol in Systemic Lupus Erythematosus
2024-09-25
【Insights】IL-17: UCB presents new 4-year data for BIMZELX[®](bimekizumab) in moderate to severe plaque psoriasis at EADV 2024
2024-09-25
【Insights】PD-1/VEGF:GlycoMimetics enters into acquisition agreement with Crescent biopharma
2024-11-01
【Insights】CD19/CD20/CD3:GSK enters agreement to acquire CMG1A46 from Chimagen Bioscience
2024-11-01
【Insights】BTK:Sanofi Announces Positive Data from Phase III Study of BTK Inhibitor ITP
2024-11-06
【Insights】GLP-1R/GCGR/GIPR: Novo Nordisk Signs $285M GLP-1 Deal With Danish Neighbor Ascendis
2024-11-06
【Insights】AstraZeneca Announces Data from First-in-Human Phase 1 Study of AZD0486, a Novel CD19xCD3 T-Cell Activator, in Relapsed/Refractory Diffuse Large B-Cell Lymphoma
2024-11-08
【Insights】HER2: FDA Approves Application for Phase I Clinical Trial of Paragon HER2 ADC for Solid Tumours
2024-11-08
First 17 18 19 20 21 Last
Total 132 Page
Jump
More
Message consultation
reset
submit
Service
Message
Message consultation
reset
submit